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Exendin-4 Protects Oxidative Stress-Induced β-Cell Apoptosis 
through Reduced JNK and GSK3β Activity 
Oxidative stress induced by chronic hyperglycemia in type 2 diabetes plays a crucial role in 
progressive loss of β-cell mass through β-cell apoptosis. Glucagon like peptide-1 (GLP-1) 
has effects on preservation of β-cell mass and its insulin secretory function. GLP-1 possibly 
increases islet cell mass through stimulated proliferation from β-cell and differentiation to 
β-cell from progenitor cells. Also, it probably has an antiapoptotic effect on β-cell, but 
detailed mechanisms are not proven. Therefore, we examined the protective mechanism of 
GLP-1 in β-cell after induction of oxidative stress. The cell apoptosis decreased to ~50% 
when cells were treated with 100 µM H2O2 for up to 2 hr. After pretreatment of Ex-4, GLP-
1 receptor agonist, flow cytometric analysis shows 41.7% reduction of β-cell apoptosis. This 
data suggested that pretreatment of Ex-4 protect from oxidative stress-induced apoptosis. 
Also, Ex-4 treatment decreased GSK3β activation, JNK phosphorylation and caspase-9, -3 
activation and recovered the expression of insulin2 mRNA in β-cell lines and secretion of 
insulin in human islet. These results suggest that Ex-4 may protect β-cell apoptosis by 
blocking the JNK and GSK3β mediated apoptotic pathway.
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INTRODUCTION 
Diabetes mellitus is a metabolic disease caused by impairment 
of pancreatic β-cell insulin secretion and increase of peripheral 
insulin resistance. In diabetes, hyperglycemia developed by pro-
gressive failure of pancreatic β-cells. Reduced β-cell mass cannot 
secrete sufficient amounts of insulin to compensate for the pe-
ripheral insulin resistance (1, 2). Sustained and prolonged hy-
perglycemia triggers the development the late micro- and mac-
ro- complications of diabetes (3, 4), also progressive deteriora-
tion of β-cell mass and insulin synthesis (5, 6). Oxidative stress 
and accelerated production of reactive oxygen species (ROS) 
induced by chronic hyperglycemia plays a key role in diabetic 
progression and further β-cell loss (5, 7, 8). Although β-cell and 
tissue damage caused by hyperglycemia-induced oxidative stress 
has been studied considerably in recent years, exact mechanism 
and effective therapeutic strategies are still not proven.
  Recent evidence has supported the importance of oxidative 
stress on antiapoptotic pathway (9, 10). The c-Jun-N-terminal 
kinase (JNK), also known as stress-activated protein kinase 
(SAPK), is activated by oxidative stress (11). Also, signaling 
through PI3-kinase and Akt are well-established activators of 
survival in numerous cell types, and overexpression of Akt spe-
cifically in pancreatic islet β-cells resulted in marked expansion 
of cell number and size (12, 13). Inhibition of Glycogen syn-
thase kinase 3β (GSK3β), the first substrate phosphorylated by 
Akt (14), by growth factor may be an important mechanism to 
promote β-cell survival and inhibit apoptosis (15, 16).
  Glucagon like peptide-1 (GLP-1), incretin hormone secreted 
from intestinal L cell, stimulates glucose-dependent insulin se-
cretion in β-cell (17-19). It has trophic factor-like properties, 
acting to stimulate β-cell growth and differentiation by interac-
tion with GLP-1 receptor (GLP-1R), a member of the Gs-pro-
tein-coupled receptor superfamily (17-19). Also, GLP-1 may 
have an antiapoptotic effect on β-cell (20), but detailed mecha-
nisms are not proven.
  Therefore, we examined the protective mechanism of Ex-4 
(GLP-1R agonist) in β-cell line and human islet by blocking the Kim J-Y, et al.  •  Protective Effects of Pancreatic β-cell by Exendin-4 
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GSK3β and JNK mediated apoptotic pathway in oxidative dam-
age.
 
MATERIALS AND METHODS
Cell culture and treatments
HIT-T15 cells, a hamster-derived insulin-secreting cell line, were 
grown in RPMI1640 medium supplemented with 10% heat-in-
activated FBS, penicillin (100 U/mL), streptomycin (100 μg/mL), 
2 g/L NaHCO3 and glucose was adjusted to 11.1 mM. The cell 
culture was maintained at 37°C in a humidified atmosphere con-
taining 5% CO2. Before experiments cells, at 80% confluence, 
were starved for 12 hr in 0.5% FBS-containing RPMI1640 and 
then incubated with the H2O2 (100 μM) (Acros organics, Geel, 
Belgium) for the indicated time. HIT-T15 cells and human islet 
was pretreated with H89 (10 μM) (Calbiochem, San Diego, CA, 
USA) or SP600125 (20 μM) (Calbiochem, San Diego, CA, USA). 
After 30 min, Ex-4 (25 nM) (Bachem Bioscience, King of Prus-
sia, PA, USA), NAC (5 mM) (Sigma, St. Louis, MO, USA) or for-
skolin (20 μM) (Calbiochem, San Diego, CA, USA) were added 
to cells for 1 h before treatment of H2O2.
Human islet isolation and culture
We obtained human islets from Kwang-Won Kim, M.D. in Sam-
sung Medical Center (SMC) in Seoul, Korea. According to the 
report from SMC, human pancreases were procured from brain-
dead donors after informed consent had been obtained from 
the donors’ relatives at the Samsung Medical Center. Islets were 
isolated from the whole pancreas using a mechanical and en-
zymatic dissociation process that has been previously described 
(21). Briefly, the ducts were perfused with a collagen digest en-
zyme (Liberase human islet, Roche, Indianapolis, IN, USA). The 
islets were then separated and purified with the use of continu-
ous gradients of Ficoll-diatrizoic acid (Seromed-Biochrom KG, 
Berlin, Germany). The islets were counted and scored for size 
on samples taken from the preparations. After isolation, the is-
lets were cultured for 48 hr for assay and experiment procedures. 
Then, extracted proteins for western blot analysis and collected 
media for insulin assay was done.
MTT reduction assay
Cell viability was measured with blue formazan that was me-
tabolized from 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-tet-
razolium bromide (MTT) (Sigma, St. Louis, MO, USA) by mito-
chondrial dehydrogenase, which are active only in live cells. 
Briefly, HIT-T15 cells were seeded in 24-well plates (1.0×10
5 
cells/mL) and incubated in RPMI 1640 medium for 24 hr. Then, 
the medium was changed to 0.5% FBS-containing RPMI1640 
and cells were incubation for 12 hr. After being incubated with 
the H2O2 (100 μM) for the indicated time, MTT reagent (5 mg/
mL) was added to each of the wells, and the plate was incubat-
ed for an additional 4 hr at 37°C. The media were then removed, 
and the intracellular formazan product was dissolved in 250 μL 
of DMSO. The absorbency of each well was then measured at 
540 nm (ref. 650 nm) using the microplate reader (Molecualr 
Devices Emax, Sunnyvale, CA, USA). OD values from untreated 
control cells were designated 100% as a standard.
Cell staining
Apoptosis was investigated by staining the cells with Hoechst 
33342 (Sigma, St. Louis, MO, USA). HIT-T15 cells were washed 
twice with PBS and then fixed in PBS containing 10% formalde-
hyde for 4 hr at room temperature. Fixed cells were washed with 
PBS and stained with Hoechst 33342 for 30 min at room tem-
perature. Cells were evaluated under a fluorescence microscope 
(OlympusBX51; Olympus Corp., Tokyo, Japan) for nuclei show-
ing typical apoptotic features such as chromatin condensation 
and fragmentation. Photographs were taken at a magnification 
of ×400.
Flow cytometric analysis
Surface exposure of phosphatidyl serine in apoptotic cells was 
quantitatively detected using Annexin V-FITC and PI apoptosis 
detection kit (Beckton Dickinson Bioscience, San Jose, CA, USA). 
Briefly, cells were seeded into 6-well plates (1.0×10
6 cells/mL) 
and incubated for 24 hr. Then, the medium was changed to 0.5% 
FBS-containing RPMI1640 and cells were starved for 12 hr. After 
treatment with the H2O2 for varying times, the cells were har-
vested and washed twice with ice-cold PBS. After 5 min of cen-
trifuging at 5,000 rpm, Annexin V-FITC and PI double-staining 
were performed according to manufacturer’s instruction. Cell 
apoptosis was analyzed on a FACSscan flow cytometry (Beck-
ton Dickinson, San Jose, CA, USA). Annexin V-FITC-positive, 
PI-negative cells were scored as apoptotic. Double-stained cells 
were considered either as necrotic or as late apoptotic (22).
Caspase activity analysis
Caspase-3, -8 and -9 activities were determined by a colorimet-
ric assay using kits from R&D System (Wiesbaden-Nordenstadt, 
Germany), according to the manufacturer’s protocol. Briefly, 
cells were lysed in the supplied lysis buffer and were incubated 
on ice for 10 min. At the end of the incubation, cell lysates were 
centrifuged at 10,000×g for 10 min at 4°C to precipitate cellular 
debris. The supernatants were collected and incubated with the 
supplied reaction buffer containing dithiothreitol and DEVD-
pNA (specific for caspase-3) or IETD-pNA (specific for caspase-8) 
and LEHD-pNA (specific for caspase-9) as substrates at 37°C. 
The reaction was measured by changes in absorbance at 405 nm 
using an ELISA reader (Molecualr Devices Emax, Sunnyvale, 
CA, USA). Enzyme activity was expressed as the fold increase in 
the proportion of apoptotic cells over that of non-treated con-
trol cells.Kim J-Y, et al.  •  Protective Effects of Pancreatic β-cell by Exendin-4 
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Quantitative real-time RT-PCR
Total RNA was isolated from the HIT-T15 cells using TRIzol re-
agent (Invitrogen, Carlsbad, CA, USA) according to the manu-
facturer’s instruction. Equal amounts of total RNA was reverse 
transcribed to cDNA using ImProm-II
TM reverse transcriptase 
(Promega, Madison, WI, USA) and oligo(dT)15 primer (Pro-
mega). Real-time PCR was conducted using DNA Engine Opiti-
con System (MJ Research Inc., Watertownm, MA, USA) in 20 μL 
reaction mixture containing 10 μL of SYBR Premix Ex Taq (Ta-
kara Bio Inc., Otsu, Japan), 2 pM of forward primer, 2 pM of re-
verse primer, and 1 μg of cDNA. Amplification parameters con-
sisted of an initial denaturation at 95°C for 5 min and 40 cycles 
of three-step PCR (a denaturation at 95°C for 1 min, an anneal-
ing at 55°C for 30 sec, and an extension at 72°C for 1 min). Ex-
pression levels of the house keeping gene GAPDH were used to 
control for differences in loading and cDNA synthesis efficiency 
between samples. The expression levels of Insulin2 mRNA were 
displayed as the cycle of threshold (Ct) value normalized to the 
GAPDH mRNA value. To determine the relationship between Ct 
values and mRNA levels, primers were calibrated by using seri-
al dilution of cDNA. We confirmed good correlations between 
Ct values and cDNA dilutions in both primer sets. We used prim-
er for Insulin2 (5´-TGTGGTTCTCACTTGGTGGA-3´ 5´-GCTC-
CAGTTGTGCCACTTGT-3´) and GAPDH (5´-AAGTTCAACG-
GCACAGTCAA-3´ 5´-TACTCAGCACCAGCATCACC-3´).
Western blot analysis
Whole cell lysates were prepared by lysis cells in Proprep-pro-
tein extraction solution (Intron Biotechnology, Seoul, Korea) 
containing 10 mM sodium phosphate (pH 7), 1% Triton X-100, 
0.1% SDS, 2 mM EDTA, 150 mM NaCl, 50 mM NaF, 0.1 mM so-
dium vanadate, 4 μg/mL leupeptin, 1 mM PMSF, and protein 
concentration of the lysates were measured with a Bio-Rad pro-
tein assay kit (Bio-Rad, Hercules, CA, USA). Equal amounts of 
proteins (20 μg) were separated on a 4-20% SDS-PAGE and 
transferred by electroblotting to a nitrocellulose membrane. 
The membranes were washed with PBST containing 5% nonfat 
dry milk at room temperature and incubated for 2 hr with the 
primary antibodies under the same conditions. The following 
primary antibodies were used: anti-JNK, anti-Thr183/Tyr185 
phosphospecific JNK, anti-caspase-9, anti-caspase-3 (Cell sig-
naling, Beverly, MA, USA); anti-Akt antibody, anti-Ser473 phos-
phospecific Akt, anti-GSK3β, anti-Ser9 phosphospecific GSK3β 
(Upstate, Lake Placid, NY, USA); anti-β-actin (for internal con-
trol) (Sigma, St. Louis, MO, USA). The membranes were washed 
in PBST, and incubated for 1 hr with horseradish peroxidase-con-
jugated sheep anti-mouse and donkey anti-rabbit immuno-
globulin antibody (1:500) (Amersham Pharmacia Biotechnolo-
gy, Tokyo, Japan) under the same conditions. After washing 
with PBST, the specific signals were detected with an enhanced 
chemiluminescense detection system (Amersham Pharmacia 
Biotechnology, Tokyo, Japan). Reagents for electrophoresis were 
obtained from Bio-Rad Laboratories (Hercules, CA, USA).
Insulin secretion assay
Insulin concentrations in the human islet culture medium were 
measured with the human ELISA insulin kit (Linco Research, 
St. Charles, MO, USA) according to the manufacturer’s instruc-
tions and insulin concentrations were calculated using the mi-
croplate reader (Molecualr Devices Emax, Sunnyvale, CA, USA).
Statistical analysis
Experiments were separately conducted at least three times, 
and data are expressed as the means±SE. The statistical differ-
ences were analyzed using the one-way ANOVA followed by 
Turkey test. The SPSS statistical software package (Version 14.0, 
Chicago, IL, USA) was used for the statistical analysis.  
RESULTS
Protective effects of the Ex-4 on oxidative stress
To determine the time and dose conditions in β-cell apoptosis 
by oxidative stress, we performed the MTT assay. HIT-T15 cells 
treated with H2O2 (100 μM) had been shown to reduce cell via-
bility in a time-dependent manner (Fig. 1A). The cell viability 
decreased to ~50% when cells were treated with 100 μM H2O2 
for up to 2 hr. Then, we investigated the effects of the Ex-4 on ox-
idative stress-induced apoptosis. As seen in Fig. 1B, MTT assay 
shows that treatment of the cells with Ex-4 significantly increased 
oxidative stress-reduced cell viability. Also, we evaluated apop-
totic nuclear condensation and fragmentation of HIT-T15 cells 
after Ex-4 and NAC treatment under oxidative stress (Fig. 1C). 
The morphological observations of H2O2 treated cells revealed 
marked chromatin condensation and the formation of apop-
totic bodies, whereas the treatment of Ex-4 or NAC in these con-
ditions reduced apoptotic bodies. In order to further clarify these 
results, we investigated protective effect of Ex-4 through flow 
cytometric analysis (Fig. 1D). As expected, the Ex-4 or NAC treat-
ment reduced H2O2-induced apoptosis. For example, the apop-
tosis ratio of the control and those treated with H2O2 were 9.4% 
and 45.5%, respectively, when treated Ex-4 or NAC, the apopto-
sis ratio was 3.8% or 10.2%, respectively. These data suggested 
that pretreatment of Ex-4 protect from oxidative stress-induced 
apoptosis.
Ex-4 may protect oxidative stress-induced apoptosis 
through PI3-kinase/Akt/GSK3β and JNK signaling 
pathway in human islet
To investigate the mechanism of the cell protective effect in-
duced by GLP-1 under oxidative stress, we examined that the 
protective effect of Ex-4 in oxidative stress-activated apoptosis 
was associated with PI3-kinase/Akt/GSK3β and phospho-JNK Kim J-Y, et al.  •  Protective Effects of Pancreatic β-cell by Exendin-4 
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reduction in human islet (Fig. 2) and HIT-T15 cells (data not 
shown). Fig. 2A shows that H2O2 treatment reduced phospho-
Akt (Ser 473) and phospho-GSK3β (Ser-9), but pretreatment of 
NAC, Ex-4 or forskolin maintained or increased its phosphory-
lation. Also, exposure of human islet to H2O2 activated JNK 
through its phosphorylation. In these conditions, pretreatment 
of Ex-4 or forskolin blocked JNK phosphorylation. The PKA in-
hibitor H89 abolished Ex-4 and forskolin effects through de-
creased phospho-Akt (Ser 473) and phospho-GSK3β (Ser-9) and 
increased phospho-JNK. Next, we found that JNK inhibition by 
SP600125, JNK inhibitor, resulting from increased GSK3β (Ser-
9) phosphorylation (Fig. 2B). These data demonstrated that the 
oxidative stress-induced apoptosis might be associated with 
PI3-kinase/Akt/GSK3β and JNK signaling pathway, and sug-
gested that Ex-4 protects GSK3β induced and JNK mediated 
apoptotic pathway.
  For apoptosis to proceed, the activation of a family of caspas-
es plays a pivotal role. Caspases-8 and -9, as initiators, are acti-
vated through self-processing, and cleave downstream procas-
pase-3 to the active form of caspase-3, which functions as the 
executor of apoptosis (23). To determine whether apoptosis via 
JNK and PI3-kinase/Akt/GSK3β ultimately is induced the acti-
vation of these caspases, HIT-T15 cells were exposed to oxida-
tive stress and the levels of caspases-8, -9 and caspase-3 were 
examined with regard to enzyme activity using a colorimetric 
assay and western blot (Fig. 3). As shown in Fig. 3A, H2O2-in-
duced apoptosis increases the activity of caspase-9 and -3 by 2.1- 
and 3.4-fold, respectively compared with the controls, whereas 
pretreatment of Ex-4 or NAC in these conditions reduced the 
activity of caspase-9 and -3. H89 abolished the attenuation of 
caspase-9 and -3. However, H2O2 did not induce the activation 
of caspase-8. Likewise, the active form of caspase-9 and -3 were 
expressed in H2O2-treated cells and reduced in Ex-4 or NAC 
treated cells (Fig. 3B). Thus, β-cell apoptosis through JNK and 
PI3-kinase/Akt/GSK3β in oxidative stress condition finally is 
induced caspase activity, and this apoptotic activity is involved 
a mitochondrial pathway. Also, β-cell-protective effects of Ex-4 
or NAC is induced through inhibition of the caspase activity by 
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mitochondrial pathway in these conditions.
  Finally, to investigate whether Ex-4 increases the practical 
ability of insulin secretion, we performed change of insulin2 
mRNA in β-cell line and insulin secretion in human islet. As 
shown in Fig. 4, under H2O2-treatment condition, expression of 
insulin2 mRNA and insulin secretion were decreased remark-
ably, but treatment of NAC or Ex-4 in oxidative stress was recov-
A B
Fig. 2. Protective effect of Ex-4 on oxidative stress-induced apoptosis via PI3-kinase/Akt/GSK3β and JNK signaling pathway in human islet. Human islet was pretreated with 
H89 (PKA inhibitor, 10 µM) or SP600125 (JNK inhibitor, 20 µM). After 30 min, human islet was treated Ex-4 (25 nM), NAC (5 mM) or forskolin (20 µM), for 1 hr before stress 
induction. After treatment of H2O2 (100 µM, 2 hr), (A) In oxidative stress condition, expression change of total Akt, GSK3β, JNK, phospho-Akt (Ser 473), phospho-GSK3β (Ser-9) 
and phospho-JNK were assessed by western blot. (B) Total JNK, GSK3β, phospho-GSK3β (Ser-9) and phospho-JNK were detected in the absence or presence of SP600125. 
These results are representative of three independent experiments.
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ered dramatically.
 
DISCUSSION
The long-acting GLP-1R agonist Ex-4 represents a new promis-
ing class of drugs for treatment of diabetes. In our current study, 
we have demonstrated that the protective effect and mecha-Kim J-Y, et al.  •  Protective Effects of Pancreatic β-cell by Exendin-4 
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nism of Ex-4 in oxidative stress-induced β-cell apoptosis. GLP-1 
and GLP-1R agonist Ex-4 enhance insulin release, increase in-
sulin biosynthesis, promote β-cell development/replication, 
and prevent β-cell exhaustion under the diabetic conditions 
(17-19). Also, GLP-1 and GLP-1R agonist Ex-4 may have an an-
tiapoptotic effect on β-cell (20), but detailed mechanisms are 
not proven.
  It has been suggested that various pathways which cause β- 
cell damage participate in the hyperglycemia induced apopto-
sis in β-cell damage (5, 10). There is considerable evidence that 
hyperglycemia results in the generation of reactive oxygen spe-
cies (ROS), ultimately leading to increased oxidative stress, and 
chronic hyperglycemia triggers the development the late com-
plications of diabetes (1, 2, 5). Also, β-cells are considered to be 
very sensitive to oxidative stress (9, 10), and resultant apoptotic 
cell death was reported to occur in diabetic model animals (9, 
24). 
  Under diabetic conditions, oxidative stress is induced in vari-
ous tissues, leading to activation of the JNK pathway (9, 10). Ac-
tivation of this pathway is involved in the deterioration of pan-
creatic β-cell function (9, 10). Inhibition of either the PKA or PI3-
kinase/Akt/GSK3β pathway, the two major pathways through 
which Ex-4 triggers its anti-apoptotic effects, showed that PKA 
and PI3-kinase/Akt/GSK3β was responsible for Ex-4 mediated 
blocking of the JNK signaling. Incubation of the human islet β- 
cells with forskolin, activators of the cAMP/PKA pathway, mim-
icked the effects of Ex-4 on the JNK phosphorylation (Fig. 3). 
Also, H89, a pharmacological inhibitor of the PKA, efficiently 
antagonized the effects of forskolin on the JNK activity (Fig. 3). 
In this report, we showed that the protection mediated by Ex-4 
is associated with an inhibition of the JNK pathway. Indeed, we 
found that JNK inhibition in human islet β-cells treated with 
SP600125 specifically stimulated the phosphorylation of GSK3β 
(Fig. 3). GSK3β is a well-characterized downstream target of 
growth factor-activated PI3-kinase/Akt signaling (14, 15). We 
showed that oxidative stress is attenuated Akt phosphorylation 
and resultant dephosphorylation of GSK3β. Ex-4 treatment re-
duced ER stress-induced apoptosis and was also associated 
with reductions in the dephosphorylation of Akt and GSK3β. 
The conclusion is that GSK3β by JNK activation modulates sus-
ceptibility to oxidative stress-induced apoptosis, rather than its 
activity being altered by apoptosis or impaired insulin secretion, 
was shown by reduction of GSK3β expression. Several transcrip-
tion factors are potential targets whereby this kinase could pro-
mote apoptosis (25). For example, CREB upregulates the ex-
pression of the antiapoptotic protein Bcl-2, and the inhibition 
of CREB activity by GSK3β may contribute to the proapoptotic 
effects of GSK3β (26, 27). Moreover, β-cell apoptosis via JNK 
and PI3-kinase/Akt/GSK3β in oxidative stress condition ulti-
mately is induced by caspase activity involved a mitochondrial 
pathway (Fig. 4). However, the precise proapoptotic targets of 
GSK3β through JNK activation during oxidative stress in β-cell 
remain to be identified.
  JNK and Akt/GSK3β inhibition by Ex-4 on oxidative stress-
induced apoptosis leads to improved insulin sensitivity. Our 
study investigated that Ex-4 increased the practical ability of in-
sulin secretion, through increase of insulin2 mRNA in β-cell 
line and insulin secretion in human islet by Ex-4 treatment on 
oxidative stress condition. Thus it is possible that protective ac-
tion of Ex-4 against oxidative stress could be involved as a treat-
ment for type 2 diabetes.
  In conclusion, we showed that the potent inhibitory effect       
of GLP-1/cAMP/PKA system on the JNK and PI3-kianas/Akt/
GSK3β activity as a major mechanism for preventing β-cell apop-
tosis induced by oxidative stress. Further studies will likely clar-
ify the signaling pathways from oxidative stress to PI3-kinas/
Fig. 4. Effects of the Ex-4 on insulin secretion. Human islet was pretreated with H89 (10 µM). After 30 min, HIT-T15 cells or human islet was treated Ex-4 (25 nM) and NAC (5 
mM) for 1 hr before stress induction. After treatment of H2O2 (100 µM, 2 hr), (A) Expression levels of insulin2 mRNA were examined by real time RT-PCR in HIT-T15 cells. Data 
were expressed as the rates to the expression levels to GAPDH in the same sample. GAPDH used for loading control. (B) Insulin secretion in human islet was detected by Insulin 
ELISA kit. Data are shown as the means±SE of four independent experiments. 
*P<0.01 vs H2O2 alone; 
†P<0.01 vs Ex-4 in treated H2O2.
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Akt/GSK3β and will identify GSK3β downstream targets respon-
sible for apoptosis. This mechanism largely contributes to the 
efficiency of Ex-4 in the long time preservation of β-cells against 
apoptosis in the treatment of type 2 diabetes.
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